Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis-Reference-Cited by-同舟云学术

Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Percutaneous Coronary Intervention: A Meta‐Analysis

Published:2021-03-23 Issue:2 Volume:110 Page:424-431
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Gelbenegger Georg¹,Schoergenhofer Christian¹,Jilma Bernd¹,Gager Gloria M.¹²,Dizdarevic Al Medina²,Mamas Mamas A.³⁴,Parapid Biljana⁵,Velagapudi Poonam⁶,Siller‐Matula Jolanta M.²⁷

Affiliation:

1. Department of Clinical Pharmacology Medical University of Vienna Vienna Austria

2. Division of Cardiology Department of Internal Medicine II Medical University of Vienna Vienna Austria

3. Keele Cardiovascular Research Group Keele University Keele UK

4. Royal Stoke University Hospital Stoke‐on‐Trent UK

5. Division of Cardiology Faculty of Medicine Clinical Center of Serbia University of Belgrade Belgrade Serbia

6. Division of Cardiology University of Nebraska Medical Center Omaha Nebraska USA

7. Department of Experimental and Clinical Pharmacology Centre for Preclinical Research and Technology Medical University of Warsaw Warsaw Poland

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.2226

Reference30 articles.

1. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

3. Omitting aspirin in PCI patients: Myth or reality?

4. Aspirin for primary prevention of cardiovascular disease: a meta-analysis with a particular focus on subgroups

5. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs;European Journal of Clinical Pharmacology;2024-09-12

2. Abbreviated dual antiplatelet therapy after acute coronary syndrome;The Lancet;2024-05

3. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study;EuroIntervention;2022-12

4. Clinical pharmacology of antiplatelet drugs;Expert Review of Clinical Pharmacology;2022-09-11

5. Adenosine diphosphate‐induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t‐PAPS): Role of P2Y12‐cAMP signaling pathway;Journal of Thrombosis and Haemostasis;2022-07